Abiopharma

New Form 8-K - Mersana Therapeutics, Inc. Filed: 2025-07-03 AccNo: 0001104659-25-065785 Size: 188 KB Item 1.02: Termination of a Material Definitive Agreement

New Form 8-K - Coherus Oncology, Inc. Filed: 2025-07-03 AccNo: 0001558370-25-009085 Size: 160 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

New Form S-3 - CEL SCI CORP Filed: 2025-07-03 AccNo: 0001654954-25-007766 Size: 709 KB

New Form 4 - agilon health, inc. Filed: 2025-07-03 AccNo: 0001628280-25-034227 Size: 5 KB

New Form 4 - Intellia Therapeutics, Inc. Filed: 2025-07-03 AccNo: 0000950170-25-093844 Size: 4 KB

New Form 4 - Zai Lab Ltd Filed: 2025-07-03 AccNo: 0000905148-25-002336 Size: 8 KB

New Form 8-K - ReShape Lifesciences Inc. Filed: 2025-07-03 AccNo: 0001104659-25-065782 Size: 231 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 8-K - Azitra, Inc. Filed: 2025-07-03 AccNo: 0001641172-25-017786 Size: 224 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

New Form 8-K - IOVANCE BIOTHERAPEUTICS, INC. Filed: 2025-07-03 AccNo: 0001104659-25-065781 Size: 192 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 4 - Stereotaxis, Inc. Filed: 2025-07-03 AccNo: 0001641172-25-017797 Size: 5 KB

New Form 4 - Stereotaxis, Inc. Filed: 2025-07-03 AccNo: 0001641172-25-017791 Size: 5 KB

New Form 4 - Stereotaxis, Inc. Filed: 2025-07-03 AccNo: 0001641172-25-017788 Size: 5 KB

New Form 4 - Insight Molecular Diagnostics Inc. Filed: 2025-07-03 AccNo: 0001641172-25-017787 Size: 5 KB

New Form 4 - Stereotaxis, Inc. Filed: 2025-07-03 AccNo: 0001641172-25-017794 Size: 5 KB

New Form 424B3 - XWELL, Inc. Filed: 2025-07-03 AccNo: 0001104659-25-065776 Size: 159 KB